Company intelligence
Vahana Labs
Most AI Fails in Regulated Markets. Yours Doesn't Have To.
About Vahana Labs
We help startups building in regulated or risk-sensitive markets turn product vision into trusted, scalable execution across compliance, GTM, and AI strategy. As 3x founding team members (including a YC-backed startup) and a former exec at a Series D company acquired by a public buyer, we’ve helped early teams ship and scale AI and SaaS products that passed regulatory review and were adopted by enterprise buyers like Gilead, Takeda, and GE Healthcare. Over the last decade, we’ve: -Launched 40+ regulated products -Delivered $3B+ in revenue impact -Led AI and compliance strategy through FDA audits, M&A integration, and buyer trust reviews At Vahana Labs, we now support product and engineering teams who need to: -Validate and execute an AI or platform roadmap -Navigate FDA, HIPAA, EU AI Act, or enterprise procurement -Align product, legal, and GTM before deals or launches stall -Add executive-level product/compliance leadership without adding headcount Whether you're stuck in POC purgatory, facing enterprise buyer objections, or trying to prioritize your roadmap under regulatory pressure, let’s talk.
Verified activity
Signals from Vahana Labs
4 published signals
Presence & Recognition
Vahana Labs welcomed Erica Breese, author of Covered, to Operating in Healthtech.
Reported by Arvita Tripati, MBA
Products & Services
Vahana Labs built the FDA GenAI Comment Tracker to map public comments to FDA's 26 questions about generative AI-enabled medical devices.
Reported by Arvita Tripati, MBA
Presence & Recognition
Vahana Labs is serving as a judge for the 2026 Digital Health Hub Foundation Digital Health & AI Awards at HLTH.
Reported by Arvita Tripati, MBA
Presence & Recognition
Vahana Labs participated in the Founders Capital Summit in San Francisco on October 6, 2026, featuring hands-on workshops for health and biotech founders.
Reported by Arvita Tripati, MBA